The post reports that AbbVie is nearing an $11 billion deal to buy Apogee Therapeutics, and Regenxbio aligns with the FDA on accelerated approval for a gene therapy drug.
bloomberg-markets06/22, 10:08 PM
Related assets
Coming up for APGE
Explore next
Latest APGE news
bloomberg-markets06/22, 09:12 PM
Finnhub06/22, 07:57 PM
ZeroHedge06/22, 07:12 PM